Oncoinfluencers to Follow on Social Media: Dr. Cathy Eng
We are excited to introduce Dr. Cathy Eng, a leading expert in gastrointestinal oncology and a key advocate for innovative cancer treatments, as our next oncoinfluencer.
Cathy Eng is active on X/Twitter and LinkedIn, where she shares her insights on cancer research, clinical trials, and patient advocacy. As a Professor of Medicine, Hematology and Oncology at the Vanderbilt-Ingram Cancer Center and Co-Director of GI Oncology, her extensive experience and dedication to advancing cancer care make her an influential voice in the oncology community.
Follow Cathy Eng on X/Twitter and LinkedIn to stay informed about her latest work in gastrointestinal malignancies and clinical trials.
About Cathy Eng
Dr. Eng holds the David H. Johnson Endowed Chair of Surgical and Medical Oncology and was previously a Professor of Medical Oncology at The University of Texas MD Anderson Cancer Center. Her primary clinical research interests include clinical trials involving innovative drugs for the treatment of colorectal, anal, and appendiceal cancers. She has a particular focus on young colorectal cancer patients and the role of immunotherapy in HPV-associated cancers.
Nationally, Dr. Eng has held multiple leadership roles with organizations such as ASCO, ASCO GI, ECOG, and the NCI Rectal/Anal Task Force. Most recently, she has been appointed as the Vice-Chair for the SWOG GI Committee and the NCI GI Steering Committee.
While staying tuned for upcoming Oncoinfluencers, check out previous profiles on our website featuring influential voices in the oncology community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023